Q9Y618 (NCOR2_HUMAN) Homo sapiens (Human)
Nuclear receptor corepressor 2 UniProtKBInterProSTRINGInteractive Modelling
It is possible new templates exist for this target since these models were created.
Available Structures
31 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Ligands | ||
|---|---|---|---|---|---|---|
| Structure of HDAC3 bound to corepressor and inositol tetraphosphate |
Heteromer O15379; | 1×ZN; 1×ACT; 2×K; 2×GOL; 1×I0P; | ||||
| Assess | ||||||
| Co-ordinates and 1H, 13C and 15N chemical shift assignments for the complex of GPS2 53-90 and SMRT … |
Heteromer Q13227; | |||||
| Assess | ||||||
| Crystal structure of PPARG and NCOR2 with BAY-4931, an inverse agonist (compound 6c) |
Heteromer P37231; | 1×O0U; 2×GOL; 1×CA; | ||||
| Assess | ||||||
| Crystal structure of the human PPAR-alpha ligand-binding domain in complex with an antagonist GW647… |
Heteromer Q07869; | 1×471; | ||||
| Assess | ||||||
| Crystal structure of the BCL6 BTB domain complexed with a SMRT co-repressor peptide |
Heteromer P41182; | |||||
| Assess | ||||||
| Crystal structure of RXRalpha ligand-binding domain complexed with corepressor SMRT2 |
Heteromer P19793; | |||||
| Assess | ||||||
| Crystal Structure of the mutant Human ROR gamma Ligand Binding Domain With rockogenin. |
Heteromer P51449; | 1×82R; | ||||
| Assess | ||||||
| Ternary complex of Human ROR gamma Ligand Binding Domain With Compound T. |
Heteromer P51449; | 1×9P6; | ||||
| Assess | ||||||
| Crystal structure of histone deacetylase 4 (HDAC4) in complex with a SMRT corepressor SP1 fragment |
Heteromer P56524; | 2×K; 2×ZN; | ||||
| Assess | ||||||
| Discovery of the Second Generation ROR gamma Inhibitors Composed of an Azole Scaffold. |
Heteromer P51449; | 1×AYO; | ||||
| Assess | ||||||
| Crystal structure of PPARG and NCOR2 with an inverse agonist (compound SI-2) |
Heteromer P37231; | 1×Q5X; 1×SO4; | ||||
| Assess | ||||||
| Crystal structure of PPARgamma ligand binding domain in complex with SMRT peptide and inverse agoni… |
Heteromer P37231; | 2×EEY; | ||||
| Assess | ||||||
| Crystal structure of PPARG and NCOR2 with an inverse agonist (compound 6a) |
Heteromer P37231; | 1×O2O; | ||||
| Assess | ||||||
| Crystal Structure of the mutant Human ROR gamma Ligand Binding Domain With Compound A. |
Heteromer G1RH57; | 1×82O; | ||||
| Assess | ||||||
| Solution structure of the MYND domain from AML1-ETO complexed with SMRT, a corepressor |
Heteromer Q06455; | 2×ZN; | ||||
| Assess | ||||||
| Crystal structure of PPARG and NCOR2 with SR10221, an inverse agonist |
Heteromer P37231; | 1×A8R; | ||||
| Assess | ||||||
| Crystal structure of PPARG and NCOR2 with an inverse agonist (compound 7a) |
Heteromer P37231; | 1×Q2X; 1×GOL; | ||||
| Assess | ||||||
| Crystal structure of PPARG and NCOR2 with an inverse agonist (compound 15b) |
Heteromer P37231; | 1×Q8F; | ||||
| Assess | ||||||
| PPAR gamma LBD bound to SR10221 and SMRT corepressor motif |
Heteromer P37231; | 1×A8R; | ||||
| Assess | ||||||
| Crystal structure of histone deacetylase 4 (HDAC4) in complex with a SMRT corepressor SP2 fragment |
Heteromer P56524; | 2×K; 2×ZN; | ||||
| Assess | ||||||
| Crystal structure of PPARG and NCOR2 with BAY-5516, an inverse agonist |
Heteromer P37231; | 1×Q5O; | ||||
| Assess | ||||||
| Crystal structure of PPARG and NCOR2 with BAY-9683, an inverse agonist |
Heteromer P37231; | 1×Q4C; | ||||
| Assess | ||||||
| Crystal structure of PPARG and NCOR2 with an inverse agonist (compound 7e) |
Heteromer P37231; | 1×Q33; | ||||
| Assess | ||||||
| Crystal structure of PPARG and NCOR2 with an inverse agonist (compound 7d) |
Heteromer P37231; | 1×Q1R; | ||||
| Assess | ||||||
| Crystal structure of mutant PPARG (C313A) and NCOR2 with an inverse agonist (compound 7e) |
Heteromer P37231; | 1×Q33; | ||||
| Assess | ||||||
| Crystal structure of mutant PPARG (C313A) and NCOR2 with an inverse agonist (compound SI-1) |
Heteromer P37231; | 1×Q4O; | ||||
| Assess | ||||||
| Progesterone receptor with bound ulipristal acetate and a peptide from the co-repressor SMRT |
Heteromer P06401; | 1×2S0; | ||||
| Assess | ||||||
| Crystal structure of RXRalpha ligand-binding domain complexed with corepressor SMRT2 and antagonist… |
Heteromer P19793; | 2×RHN; | ||||
| Assess | ||||||
| Structural insights into the recruitment of SMRT by the co-repressor SHARP under phosphorylative re… |
Heteromer Q96T58; | |||||
| Assess | ||||||
| Solution structure of the SANT2 domain of the human nuclear receptor corepressor 2 (NCoR2), Northea… | monomer | |||||
| Assess | ||||||
| Solution Structure of the SMRT Deacetylase Activation Domain | monomer | |||||
| Assess | ||||||
5 SWISS-MODEL models
| Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 4a69.1.B | monomer | 0.69 | 100.00 | |||
| Assess | ||||||
| 2ltp.1.A | monomer | 0.66 | 98.57 | |||
| Assess | ||||||
| 1xc5.1.A | monomer | 0.65 | 100.00 | |||
| Assess | ||||||
| 6vyp.2.J | monomer | 0.55 | 34.48 | |||
| Assess | ||||||
| 4czz.1.B | monomer | 0.54 | 30.84 | |||
| Assess | ||||||
10 SWISS-MODEL models built on isoform sequence
| Template | Isoform | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) |
|---|---|---|---|---|---|---|
| Isoform 4 | 4a69.1.B | monomer | 0.70 | 100.00 | ||
| Assess | ||||||
| Isoform 4 | 2ltp.1.A | monomer | 0.67 | 98.25 | ||
| Assess | ||||||
| Isoform 4 | 1xc5.1.A | monomer | 0.65 | 100.00 | ||
| Assess | ||||||
| Isoform 4 | 6vyp.2.J | monomer | 0.57 | 34.48 | ||
| Assess | ||||||
| Isoform 4 | 4czz.1.B | monomer | 0.55 | 30.84 | ||
| Assess | ||||||
| Isoform 5 | 4a69.1.B | monomer | 0.68 | 100.00 | ||
| Assess | ||||||
| Isoform 5 | 2ltp.1.A | monomer | 0.65 | 98.57 | ||
| Assess | ||||||
| Isoform 5 | 1xc5.1.A | monomer | 0.64 | 100.00 | ||
| Assess | ||||||
| Isoform 5 | 6vyp.2.J | monomer | 0.56 | 34.48 | ||
| Assess | ||||||
| Isoform 5 | 4czz.1.B | monomer | 0.54 | 30.84 | ||
| Assess | ||||||